29.52
price down icon0.37%   -0.11
after-market アフターアワーズ: 29.52
loading
前日終値:
$29.63
開ける:
$29.15
24時間の取引高:
715.57K
Relative Volume:
1.60
時価総額:
$535.83M
収益:
$116.88M
当期純損益:
$-25.09M
株価収益率:
-210.86
EPS:
-0.14
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
-17.33%
1か月 パフォーマンス:
-11.14%
6か月 パフォーマンス:
-28.59%
1年 パフォーマンス:
+45.49%
1日の値動き範囲:
Value
$28.01
$30.14
1週間の範囲:
Value
$28.01
$36.57
52週間の値動き範囲:
Value
$15.50
$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
名前
Rigel Pharmaceuticals
Name
セクター
Healthcare (1108)
Name
電話
650-624-1100
Name
住所
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
職員
164
Name
Twitter
@rigelpharma
Name
次回の収益日
2026-03-03
Name
最新のSEC提出書
Name
RIGL's Discussions on Twitter

Compare RIGL vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RIGL
Rigel Pharmaceuticals
29.52 537.82M 116.88M -25.09M -20.74M -0.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-05 アップグレード Jefferies Hold → Buy
2023-04-03 再開されました Piper Sandler Neutral
2022-06-09 ダウングレード Citigroup Buy → Neutral
2022-06-08 ダウングレード Cantor Fitzgerald Overweight → Neutral
2022-06-08 ダウングレード Piper Sandler Overweight → Neutral
2022-03-23 開始されました B. Riley Securities Neutral
2020-11-09 ダウングレード JP Morgan Overweight → Neutral
2019-11-15 再開されました Cantor Fitzgerald Overweight
2019-09-26 再開されました JP Morgan Overweight
2019-03-01 繰り返されました Cantor Fitzgerald Overweight
2018-08-27 開始されました Citigroup Buy
2018-05-02 繰り返されました Cantor Fitzgerald Overweight
2017-12-21 再開されました Piper Jaffray Overweight
2017-12-15 開始されました Cantor Fitzgerald Overweight
2017-11-06 再開されました H.C. Wainwright Buy
2017-03-09 繰り返されました H.C. Wainwright Buy
2016-08-31 繰り返されました H.C. Wainwright Buy
2016-08-30 繰り返されました Piper Jaffray Overweight
2016-07-13 開始されました H.C. Wainwright Buy
2016-06-13 開始されました Piper Jaffray Overweight
2016-04-22 アップグレード JP Morgan Neutral → Overweight
2013-04-08 繰り返されました Stifel Buy
2012-11-29 開始されました UBS Neutral
2012-11-06 繰り返されました Oppenheimer Outperform
2012-03-26 開始されました Canaccord Genuity Hold
2010-12-10 ダウングレード MP Advisors Outperform → Market Perform
すべてを表示

Rigel Pharmaceuticals (RIGL) 最新ニュース

pulisher
08:21 AM

Brokers Offer Predictions for RIGL Q1 Earnings - MarketBeat

08:21 AM
pulisher
01:04 AM

Rigel Pharmaceuticals’ Fast Track Ambitions Face Significant FDA Uncertainty - TipRanks

01:04 AM
pulisher
Mar 04, 2026

This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

Rigel Pharmaceuticals (RIGL) EPS Spike On Non Cash Gains Challenges Bullish Narratives - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026 - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ) - Seeking Alpha

Mar 04, 2026
pulisher
Mar 04, 2026

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap DownWhat's Next? - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 04, 2026
pulisher
Mar 04, 2026

Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $71 - 富途牛牛

Mar 04, 2026
pulisher
Mar 04, 2026

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and Strategic Growth Initiatives - GuruFocus

Mar 04, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals Q4 2025 Earnings Call Transcript - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect - AlphaStreet News

Mar 03, 2026
pulisher
Mar 03, 2026

Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com

Mar 03, 2026
pulisher
Mar 03, 2026

Earnings call transcript: Rigel’s Q4 2025 shows robust growth - Investing.com Australia

Mar 03, 2026
pulisher
Mar 03, 2026

Earnings call transcript: Rigel’s Q4 2025 shows robust growth By Investing.com - Investing.com South Africa

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:RIGL) 2026-03-03 - Seeking Alpha

Mar 03, 2026
pulisher
Mar 03, 2026

RIGL: Record sales and net income in 2025, with strong growth outlook and pipeline progress for 2026 - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates - Bitget

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharma (RIGL) Earnings Call Transcript - Nasdaq

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals Q4 Earnings, Revenue Rise; 2026 Revenue Outlook Set - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals (RIGL) Projects FY26 Revenue Growth - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

Earnings Summary: Rigel Pharmaceuticals Q4 - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals (NASDAQ:RIGL) Announces Earnings Results - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

RIGL: Record 2025 revenue and net income, with 2026 outlook for continued growth and pipeline progress - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals reports Q4 EPS $13.54 with items, consensus $1.20 - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel (NASDAQ: RIGL) boosts blood cancer drug sales and advances pipeline - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel: Q4 Earnings Snapshot - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

RIGL: Record 2025 revenue and net income, strong product growth, and positive 2026 outlook - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

RIGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Rigel Pharmaceuticals (RIGL) Set to Announce Q4 Earnings - GuruFocus

Mar 03, 2026
pulisher
Mar 02, 2026

A Preview Of Rigel Pharmaceuticals's Earnings - Benzinga

Mar 02, 2026
pulisher
Mar 01, 2026

(RIGL) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Mar 01, 2026
pulisher
Feb 27, 2026

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options - TradingView

Feb 27, 2026
pulisher
Feb 27, 2026

RIGL.O Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026
pulisher
Feb 26, 2026

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking a 49% Potential Upside for Investors - DirectorsTalk Interviews

Feb 26, 2026
pulisher
Feb 26, 2026

Rigel Pharmaceuticals Options See Significant Rise in Implied Volatility - Bitget

Feb 26, 2026
pulisher
Feb 24, 2026

Walter Moos Sells 4,000 Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Rigel (RIGL) director Moos exercises options and sells 4,000 shares - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? - Finviz

Feb 24, 2026
pulisher
Feb 24, 2026

IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential? - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - The AI Journal

Feb 24, 2026
pulisher
Feb 24, 2026

Rigel Pharmaceuticals (RIGL) Projected to Post Earnings on Tuesday - MarketBeat

Feb 24, 2026
pulisher
Feb 22, 2026

Will Tavalisse continue to drive Rigel Pharmaceuticals' growth in 2026? - MSN

Feb 22, 2026
pulisher
Feb 21, 2026

Rigel Pharmaceuticals (NASDAQ:RIGL) Upgraded at Zacks Research - Defense World

Feb 21, 2026
pulisher
Feb 20, 2026

How interest rate cuts could boost Rigel Pharmaceuticals Inc. stock2025 Analyst Calls & Weekly Top Performers Watchlists - mfd.ru

Feb 20, 2026

Rigel Pharmaceuticals (RIGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
大文字化:     |  ボリューム (24 時間):